KRISTI BROWN: Open Payments
NPI 1720412059 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,205 in 118 payments from 24 companies in 2025. Trend: 2023 $2,136 · 2024 $1,945 · 2025 $2,205
Food & beverage: $2,205
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $389 |
| AstraZeneca Pharmaceuticals LP | 9 | $272 |
| ABBVIE INC. | 12 | $196 |
| GlaxoSmithKline, LLC. | 12 | $180 |
| Amgen Inc. | 15 | $149 |
| Xeris Pharmaceuticals, Inc. | 6 | $116 |
| PFIZER INC. | 5 | $106 |
| Otsuka America Pharmaceutical, Inc. | 5 | $98 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $96 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $95 |
Products named: Ozempic, OTEZLA, Rybelsus, TRELEGY ELLIPTA, BREZTRI, REXULTI, CAPLYTA, GVOKE HYPOPEN.
Industry payments across TN — which companies pay providers there.
